1. Home
  2. ASTL vs CAPR Comparison

ASTL vs CAPR Comparison

Compare ASTL & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTL
  • CAPR
  • Stock Information
  • Founded
  • ASTL 1902
  • CAPR 2005
  • Country
  • ASTL Canada
  • CAPR United States
  • Employees
  • ASTL N/A
  • CAPR N/A
  • Industry
  • ASTL Steel/Iron Ore
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ASTL Industrials
  • CAPR Health Care
  • Exchange
  • ASTL Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • ASTL 1.1B
  • CAPR 867.6M
  • IPO Year
  • ASTL N/A
  • CAPR N/A
  • Fundamental
  • Price
  • ASTL $9.65
  • CAPR $13.01
  • Analyst Decision
  • ASTL
  • CAPR Strong Buy
  • Analyst Count
  • ASTL 0
  • CAPR 7
  • Target Price
  • ASTL N/A
  • CAPR $39.29
  • AVG Volume (30 Days)
  • ASTL 428.3K
  • CAPR 1.5M
  • Earning Date
  • ASTL 02-04-2025
  • CAPR 11-13-2024
  • Dividend Yield
  • ASTL 2.09%
  • CAPR N/A
  • EPS Growth
  • ASTL N/A
  • CAPR N/A
  • EPS
  • ASTL N/A
  • CAPR N/A
  • Revenue
  • ASTL $1,840,778,711.00
  • CAPR $23,228,045.00
  • Revenue This Year
  • ASTL N/A
  • CAPR N/A
  • Revenue Next Year
  • ASTL $15.21
  • CAPR $74.85
  • P/E Ratio
  • ASTL N/A
  • CAPR N/A
  • Revenue Growth
  • ASTL N/A
  • CAPR 65.33
  • 52 Week Low
  • ASTL $6.67
  • CAPR $3.52
  • 52 Week High
  • ASTL $12.14
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • ASTL 31.74
  • CAPR 37.54
  • Support Level
  • ASTL $9.36
  • CAPR $13.00
  • Resistance Level
  • ASTL $10.19
  • CAPR $20.75
  • Average True Range (ATR)
  • ASTL 0.27
  • CAPR 1.60
  • MACD
  • ASTL -0.12
  • CAPR -0.30
  • Stochastic Oscillator
  • ASTL 10.67
  • CAPR 11.04

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a Canadian company engaged in the production of clean and consistent light gauge steel. The company offers a range of hot and cold rolled steel sheet and plate products. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.

Share on Social Networks: